Share on LinkedInShare on LinkedIn

ARTICLE · 05 JUNE 2020

Pause On PMPRB Reform: Implementation Of New Pricing Regulations Delayed To 2021

Torys
Torys
Contributor
Torys

Torys

Torys LLP is an international business law firm that works with clients who expect the best advice...

View firm profile
Explore more from Torys

The Patented Medicine Prices Review Board (PMPRB) has announced a delay in the coming-into-force of the amended Patent Medicines Regulations (the Regulations) to January 1, 2021.

CanadaIntellectual Property

The Patented Medicine Prices Review Board (PMPRB) has announced a delay in the coming-into-force of the amended Patent Medicines Regulations (the Regulations) to January 1, 2021.

What you need to know

  • The Regulations were initially to come into force on July 1, 2020. This implementation date has now been delayed to January 1, 2021.
  • PMPRB has indicated that draft Guidelines to operationalize the Regulations will be published during the week of June 15, 2020 and will be subject to a 30-day consultation period.
  • PMPRB also states that the final Guidelines will include transitional measures to give industry time to adapt and voluntarily comply with the new regulatory requirements.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from